Innovative platform integrating sensing, connectivity, and ASIC intelligence to debut at MEDICA 2025
Linxens, a global leader in component-based solutions, and Presto Engineering, a leading provider of advanced ASIC design and production services, today announced a strategic collaboration on a next-generation platform of connected biosensors. The initiative will be showcased at MEDICA 2025, the world’s largest medical trade fair, where Linxens and Presto Engineering will share the first results of this collaboration.
The collaboration lays the foundation for a scalable platform that integrates sensing, connectivity, and semiconductor intelligence into a single disposable device. By combining Presto’s next-generation ASIC (application-specific integrated circuit) capabilities with Linxens’ expertise in flexible biosensor transducers, electrodes, antennas, and high-volume industrial manufacturing, the companies are working toward a biosensor platform that is powerful, cost-efficient, and adaptable across diverse applications.
The platform is designed around four guiding principles:
Affordability and disposability for cost-sensitive healthcare contexts,
Compact and lightweight construction enhanced comfort and usability,
Digital connectivity for standardized results
Industrial scalability supported by Linxens’ high-volume manufacturing expertise.
Design flexibility to support multiple formats and use cases
Designed as a flexible, modular platform, the solution supports a wide range of use cases - from faster, contamination-free point-of-care testing and discreet wearable monitoring to rapid on-site analysis in food safety and environmental control. Its architecture enables quick adaptation to emerging diagnostic needs while preserving scalability and cost efficiency. By framing their initiative as a platform concept, Linxens Healthcare - Linxens' dedicated health brand - and Presto Engineering aim to deliver faster workflows, enhanced portability for field or low-resource settings, and more comfortable, discreet monitoring devices that can improve patient adherence. In industrial and environmental contexts, it supports on-site testing of pathogens or contaminants, helping to ensure safety and deliver fast, digital results in process-critical environments.
“This collaboration is about more than just a new concept — it’s about laying the foundation for a platform that makes connected diagnostics practical, affordable, and scalable for real-world healthcare,” said Pierre O. Beal, Healthcare Product Strategy Manager at Linxens Healthcare. “We see this as a basis for future innovation in testing and monitoring, empowering providers and patients with reliable digital data at the point of need.
“From a technology standpoint, the breakthrough lies in embedding intelligence directly into the biosensor platform,” explained Frédéric Valentin, SVP Sales & Marketing at Presto Engineering. “Our next-generation silicon platform brings secure connectivity and advanced signal processing into a compact, disposable format. When combined with Linxens’ flexible electronics and industrial-scale manufacturing, it creates a versatile architecture that can be tailored to applications ranging from infectious disease testing to wearable patient monitoring.”
➡️ Interested in a demo of the biosensor?
➡️ Learn more about Presto's Silicon platforms